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The validity of the ﬂow-mediated dilation test has been questioned due to the lack of normalization to the primary stimulus, shear
stress. Shear stress can be calculated using Poiseuille’s law. However, little attention has been given to the most appropriate blood
velocity parameter(s) for calculating shear stress. The pulsatile nature of blood ﬂow exposes the endothelial cells to two distinct
shearstimuliduringthecardiaccycle:alargerateofchangeinshearattheonsetofﬂow(velocityacceleration),followedbyasteady
component. The parameter typically entered into the Poiseuille’s law equation to determine shear stress is time-averaged blood
velocity, with no regard for ﬂow pulsatility. This paper will discuss (1) the limitations of using Posieuille’s law to estimate shear
stressand(2)theimportanceofthevelocityproﬁle—withemphasisonvelocityacceleration—toendothelialfunctionandvascular
tone.
1.Introduction
The pathological complications of atherosclerosis, namely,
heart attacks and strokes, remain the leading cause of mor-
tality in the Western world [1]. Preceding atherosclerosis is
endothelial dysfunction [2–4]. The ﬂow-mediated dilation
(FMD) test has emerged as the noninvasive standard for
assessing in vivo endothelial function [5]. Despite its poten-
tial, the validity of the FMD test has been questioned due to
the lack of normalization to the primary stimulus, shear
stress [6–10]. Fortunately, the ultrasound technology used
to conduct the FMD test can also provide estimates of shear
stress [11]. Typically, shear stress is estimated by employing
a simpliﬁed mathematical model based on Poiseuille’s law.
More sophisticated approaches using magnetic resonance
imaging are available, but are beyond the reach of most clin-
ical studies since such techniques are not readily available,
are too expensive, and are technically challenging and time
consuming [12–14].
Little attention has been given to the most appropriate
blood velocity parameter(s) for calculating shear stress. The
pulsatile nature of blood ﬂow exposes the endothelial cells to
twodistinctshearstimuliduringthecardiaccycle:alargerate
of change in shear at the onset of ﬂow (velocity acceleration),
followed by a steady shear component. In vitro studies sug-
gest that these two distinct ﬂuid stimuli regulate short- and
long-term endothelial function via independent biomechan-
ical pathways [15–17]. The parameter typically incorporated
into the Poiseuille’s law equation for shear stress is time-ave-
raged blood velocity, that is, blood velocity averaged across
the cardiac cycle, with no regard to ﬂow pulsatility. This
paper will discuss (1) the limitations of using Posieuille’s law
toestimateshearstressand(2)theimportanceofthevelocity
proﬁle—with emphasis on velocity acceleration—to endo-
thelial function and vascular tone.
2.Flow-MediatedDilation
The FMD test is a noninvasive method of evaluating endo-
thelial function. A number of authors have developed stan-
dardized guidelines for conducting this test [18–20], includ-
ing a recent article by Thijssen and colleagues [21]. The2 International Journal of Vascular Medicine
standard FMD test, as ﬁrst described by Celermajer et al.
[22], places a pneumatic tourniquet forearm just below the
elbow and distal to imaged brachial artery. The tourniquet
is inﬂated to a suprasystolic blood pressure for 5 minutes.
Rapid deﬂation of the tourniquet instigates increased blood
ﬂow (reactive hyperemia) to the oxygen starved forearm
muscles, with a subsequent increase in ﬂow through the up-
stream brachial artery. The ﬂow-induced increase in shear
stress results in vasodilation of the brachial artery. The mag-
nitude of FMD, expressed as the percentage increase in dia-
meter above rest, is used to represent endothelial health.
3. ShearStress
Despite the term ﬂow-mediated dilation, shear stress (see
Figure 1) is the established stimulus for FMD [6, 7, 10, 23–
28]. Shear stress is determined by red blood cells moving
close to the endothelial cells. As the ﬂuid particles “travel”
parallel to the wall, their velocity increases from zero at
the wall to a maximum value at some distance from the
wall. This leads to the establishment of a gradient, which is
deﬁnedasshearstress(Figure 2).Shearstressthereforeactsat
a tangent to the wall to create a frictional force at the surface
of the endothelium. The endothelial cells are equipped with
mechanosensors to detect this stress [29–38].
Tomaintainphysiologicallevelsofvesselwallshearstress,
vascular tissues respond with acute adjustments in vascular
tone through vasodilatation [39]. Vasodilation reﬂects alte-
rations in the rate of production of endothelial-derived med-
iators, including nitric oxide (NO), prostacyclin (PGI2), and
endothelial-derived hyperpolarizing factor (EDHF), which
act locally to modulate vascular smooth muscle tone.
4.ShearStressMechanotransduction
The endothelium is a complex mechanical signal-transduc-
tion interface between the vessel wall and the ﬂowing blood.
Mechanotransduction is the interaction between shear
stress-inducedbiomechanicalforcesandendothelialcellfun-
ction. Exactly how these biomechanical forces are sensed by
endothelial cells remains unclear. Two models of mechano-
transduction have been demonstrated so far, a localized mo-
del and a decentralized model.
4.1. The Localized Model. The mechanoreceptor, like other
receptors, is considered to be located in the cell membrane
(Figure 3).Channels(i.e.,K+,N a +,andCl −)locatedinmem-
branerespondtochangesinshearstress.Becauseionchannel
activationisoneofthefastestknownendothelialresponsesto
ﬂow, these ion channels are the proposed ﬂow sensors [29–
31, 33, 34, 40]. The ﬂow-sensitive ion channel ﬁrst identiﬁed
in endothelial cells was an inward-rectifying K+ channel,
whoseactivationleadstohyperpolarizationofthecellsmem-
brane [35, 36]. The second type of ﬂow-sensitive ion chan-
nel, more recently discovered, is an outward-rectifying Cl−
channel [37, 38] .T h ec h a n g ei nm e m b r a n ep o t e n t i a l ,a s s o -
ciated with the activation of these ion channels, alters the
electrochemical gradient for Ca2+ transport across the endo-
thelial cell membrane. This has been shown to provide
a mechanism of direct interaction between ﬂow-sensitive ion
channels and Ca2+-dependent pathways [37, 38].
The Cl− and K+ channels are activated independently
[37, 38]. Activation of Cl− channels leads to cell membrane
depolarization; this follows the initial K+ channel-mediated
hyperpolarization. The fact that hyperpolarization precedes
depolarization, in spite of the larger electrochemical driving
force for Cl− than K+, suggests that ﬂow-sensitive Cl− chan-
nels attain maximal activation more slowly than ﬂow-sensi-
tive K+ channels. The notion that K+ channels respond to
shear stress more rapidly than Cl− channels is expected to be
particularly relevant for situations where a time-varying
shear stress may activate one or both channels depending on
the time constant characterizing the changes in shear stress.
There is mounting evidence that ﬂow-sensitive K+ and
Cl− channelsplayacentralroleinregulatingoverallendothe-
lial responsiveness to ﬂow [41–43]. This notion is supported
by data demonstrating that interference with these candidate
mechanosensors aﬀects downstream gene and protein regu-
latory responses. For instance, pharmacological antagonists
of ﬂow sensitive K+ and Cl− channels greatly attenuate or
entirely abolish shear stress-induced release of cyclic guano-
sine monophosphate (cGMP) [41]a n dN O ,d o w n r e g u l a t e
endothelin-1 [42], and induce Na-K-Cl cotransport protein
[43].
4.2. The Decentralised Model. This model suggests that the
mechanical forces acting on the luminal side of endothelial
cells are transmitted through the cytoskeleton to other sites
within the cell [44]. The endothelial cell can be viewed as a
membrane stretched over a frame composed of intermediate
ﬁlaments and actin ﬁbers which transverse the cells and end
inadhesioncomplexes(Figure 3).Evenundernonstimulated
conditions, the entire endothelial cytoskeleton is maintained
under tension, and in response to an externally applied stim-
ulus intracellular tension is redistributed over the cytoskele-
ton network. These forces are especially sensed at the basal
adhesion points, where the endothelial cell is attached to the
extracellular matrix, cell junctions, and the nuclear mem-
brane [30]. So it is conceivable that the application of a stres-
soractivatessignaltransductioncascadeswithouttheneedof
a speciﬁc shear stress or stretch receptor. Integrins connected
to the cytoskeleton have been related to this mechanism of
mechanoreception [45].
5. Shear StressEstimation
Clinical studies in humans, including FMD studies, typically
estimate shear stress by employing a simpliﬁed mathematical
model based on Poiseuille’s law, where shear rate equals
Shear rate

γ

=
2(2+n)v
d
,( 1 )
where d is the internal arterial diameter, v is time averaged
mean blood velocity, and n represents the shape of the veloc-
ity proﬁle. For a fully developed parabolic proﬁle, n is 2.
Poiseuille’s law assumes that (1) the ﬂuid (blood) is New-
tonian; (2) blood ﬂows through a rigid tube; (3) whole
blood viscosity represents viscosity at the vessel wall and isInternational Journal of Vascular Medicine 3
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Figure 1: Haemodynamic Stress. Shear stress results in parallel deformation, as opposed to normal stress or force, which when applied to an
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Figure 2: Determination of Shear Rate (γ). As ﬂuid particles “travel” parallel to the vessel wall, their average velocity increases from a
minimum at the wall to a maximum value at some distance from the wall, resulting in a gradient of velocities. The actual shear rate at
the vessel wall is determined by shape of the velocity proﬁle. Shear stress-induced deformation of the endothelial cells is detected by
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Actin Tubulin
Cytoskeleton proteins
Basal adhesion site
Cell contact to extracellular matrix
Ion channels
Cell surface proteins
Transmembrane cytoskeleton proteins
Intracellular contact proteins
Nucleus
(cytoskeleton)
Shear stress
Figure 3: Putative Mechanisms of Mechanotransduction.T h elocalized model for shear stress mechanotransduction assumes that shear stress
sensors are located in the cell membrane. Ion channels are the proposed ﬂow sensors. The decentralized model suggests that the mechanical
forcesactingontheluminalsideoftheendothelialcellsaretransmittedthroughthecytoskeletontoothersitesinthecell.Integrinsconnected
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linearly proportional to shear rate; (4) the velocity proﬁle
is parabolic; (5) mean blood velocity adequately deﬁnes the
shear stimulus.
First, although blood is a non-Newtonian ﬂuid at low
shear rates (smaller than approx. 100s−1)[ 46] in vivo, shear
stress in large arteries, particularly at the endothelial surface,
is generally considerably larger than this threshold value so
that the eﬀect of the non-Newtonian behavior does not
appear to be pronounced. Second, blood vessels are disten-
sible, meaning that wall shear rate may be ∼30% less in a
distensible artery as compared with a rigid tube [47].
Third, the magnitude of shear stress, to which the endo-
thelialcellissubjected,isgivenbytheproductofthedynamic
viscosity of blood and shear rate. Viscosity is an internal pro-
perty of a ﬂuid that oﬀers resistance to ﬂow. For Newtonian
ﬂuids, shear rate and viscosity are directly related. However,
the relationship between shear rate and viscosity is nonlinear
for non-Newtonian ﬂuids. Human in vivo studies are usually
limited to whole blood measurements of viscosity. These
measurements overestimate the viscosity at the wall of the
vessel. Less red blood cells travel along the artery wall, where,
in addition to a thin layer of plasma, blood platelets are trav-
eling [48]. Red blood cells tend to stream in the center of the
vessel, resulting in higher viscosity in the center and there-
by reducing the shear stress gradients at the vessel wall.
It is worth noting that shear stress assessments do not
seem to result in conclusions diﬀerent from shear rate asses-
sments alone [49]. This may be explained by two factors: (1)
sources of error from whole blood viscosity estimates and
(2) blood viscosity exhibits low intrasubject variability [50],
particularly among a healthy, homogenous group. Shear rate
hasbeenusedasasurrogatemeasureofshearstressinanum-
berofpreviousstudies[49–53].Nonetheless,therelationship
betweenvascularhomeostasisandbloodviscosityiscomplex
[54]. Further study is required to determine the inﬂuence
of blood velocity on shear stress estimations, particularly for
populations exhibiting cardiovascular risk factors known to
eﬀect blood viscosity.
Fourth, in arteries, the velocity proﬁle will not develop
to a full parabola as a consequence of ﬂow unsteadiness and
short vessel entrance lengths. In both arteries and arterioles,
the velocity proﬁles are actually ﬂattened parabolas ([13], see
Figure 2B). In the common carotid artery, mean wall shear
stress is underestimated by a factor of 2 when assuming a
parabolic velocity proﬁle [55]. In the brachial artery, the
underestimation is less pronounced, likely due to a more
parabolic velocity proﬁle in this artery, that is, n (velocity
proﬁle)iscloserto2([55],seeFigure 2A).However,thismay
only be true for resting conditions; occurrence of ﬂow tur-
bulence is possible during reactive hyperemia [56].
Fifth,foragivenmeanbloodvelocity,theﬂowproﬁlecan
vary dramatically due to the pulsatile nature of circulation
[57–59]. Blood ﬂow pulsatility results in endothelial cells
being exposed to two distinct shear stimuli during the car-
diac cycle: a large rate of change (velocity acceleration) in
shear at the onset of ﬂow, followed by steady shear. In
vitro studies suggest that these two distinct stimuli regulate
short- and long-term endothelial function via independent
biomechanical pathways [60–67]. Mean blood velocity is
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Figure 4: Acceleration and Steady Shear Components. The normal
brachial arterial signal is triphasic, corresponding to the (1) rapid
blood ﬂow during systole, resulting in velocity acceleration, (2)
initial reversal of blood ﬂow in diastole, and (3) gradual return
of forward ﬂow during late diastole, resulting in steady shear
component.
therefore unlikely to characterize the shear stimulus, partic-
ularly during hyperemic conditions.
6. The Importance of the Velocity Proﬁle to
ShearStressMechanotransduction
The earliest studies investigating the eﬀects of shear stress on
endothelial function did so by assessing endothelial cell res-
ponses to high versus low shear stress. This was until Davies
et al. [68], in 1986, provided evidence that the time-averaged
shearstressalonecouldnotexplainthepathologicalbehavior
of endothelial cells exposed to complex ﬂow patterns. Sub-
sequent studies [57, 66, 69–75] have shown that vascular
endothelial cells respond not only to the time-averaged shear
stress, but respond diﬀerently to diﬀerent patterns of ﬂow.
The cyclic nature of the beating heart creates pulsatile
ﬂow conditions in all arteries. The heart ejects blood during
systole and ﬁlls during diastole. These cyclic conditions cre-
ate relatively simple monophasic ﬂow pulses in the upper re-
gion of the aorta [76]. However, pressure and ﬂow character-
istics are substantially altered as blood circulates through the
arterial tree. Figure 4 shows an example of a typical brachial
artery blood velocity proﬁle. The normal brachial arterial
signal is triphasic, corresponding to (1) rapid blood ﬂow
during systole, (2) initial reversal of blood ﬂow in diastole,
and (3) gradual return of forward ﬂow during late diastole.
The blood ﬂow proﬁle in the aorta is predominately
governed by the force of blood ejected from the heart [77].
However, in the periphery, the blood ﬂow proﬁle becomes
more complex as a result of the energy transfer between
the heart and arteries. The heart generates forward-traveling
wave energy that propagates through the arteries to maintain
tissue and organ perfusion for metabolic homeostasis. An
individual forward-traveling waveform, generated by the
heart at the beginning of systole, initiates ﬂow and increases
pressure in the arteries. Although most of the wave energyInternational Journal of Vascular Medicine 5
Mean shear
High VA Low VA
V
e
l
o
c
i
t
y
/
s
h
e
a
r
 
s
t
r
e
s
s
0
100
80
60
40
20
0
Time
0.2 0.4 0.6 0.8 1
Figure5:HighversusLowVelocityAcceleration(VA).Thehorizontal
line denotes identical mean shear stress for both VA rates.
in this initial compression wave travels distally into smaller
arteries, some is reﬂected back towards the heart at sites of
impedance mismatch. Interactions between forward- and
backward-traveling waves result in complex blood ﬂow pat-
terns. Wave reﬂections result from arterial geometry, arterial
wallcompliance,anddownstreamresistancecreatedbyresis-
tance arteries [57, 59].
Complex ﬂow characteristics have a profound impact on
the shear stress distribution to which vascular endothelial
cells are exposed. While human in vivo studies typically
describe shear stress as a mean construct, numerous sec-
ondary phenomena associated with ﬂow, including pulsatile
ﬂow, retrograde ﬂow, and ﬂow turbulence, can inﬂuence the
regulation of endothelial cells [23, 60, 62, 78–80].
6.1. Velocity Acceleration and Endothelial Function. The
pulsatile nature of blood ﬂow exposes the endothelial cells to
twodistinctshearstimuliduringthecardiaccycle:alargerate
of change in shear at the onset of ﬂow (velocity acceleration),
followed by a steady shear component (Figure 4). In vitro
studies suggest that these two distinct ﬂuid stimuli (velocity
acceleration versus steady velocity) regulate short- and long-
term endothelial function via independent biomechanical
pathways [60–67]. For a given mean blood velocity, or
shear stress, velocity acceleration can vary quite substantially
(Figure 5). Studies have shown that the rate of velocity
acceleration can aﬀect the progression of atherosclerosis
[60–62, 67, 81–85], endothelial cell function [62, 67, 86],
mechanotransduction [63–65, 83, 87], calcium kinetics [88–
91], and vascular tone [15–17, 92–94].
6.2. Velocity Acceleration and Flow-Mediated Dilation. The
endothelium mediates ﬂow-mediated vasodilation by alter-
ing the release of numerous factors, including NO, PGI2
and EDHF factor. The development of sophisticated in vitro
ﬂow models has allowed the eﬀects of velocity acceleration
on cultured endothelial cell function to be studied. Notably,
the release of NO and PGI2, from cultured endothelial cells
has been directly related to the rate of velocity acceleration
[15,16,92,93].Therateofvelocityaccelerationhasalsobeen
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Figure 6: Velocity Acceleration versus Shear Stress-Dependent Dila-
tion. Velocity acceleration (VA) and mean shear stress appear to
regulatenitricoxideproductionviadistinctpathways.Ca+:calcium;
eNOS: endothelial nitric oxide synthase; PECAM: platelet/endothe-
lial cell adhesion molecule.
directly related to vasodilation of isolated cremaster arteri-
oles [94].
The production rate of NO and PGI2 following ﬂow
onset exhibits a biphasic response, an initial transient burst
followed by a slower release to a constant rate [15, 16, 92].
Separate studies from the same group [15, 16] demonstrated
that the initial burst of NO is dependent on velocity accelera-
tion but not the shear stress magnitude; the subsequent con-
stant NO production is dependent on shear stress magnitude
(Figure 6). The initial burst of NO was found to be Ca2+ and
G-protein dependent (i.e., “localized” mechanotransduc-
tion). In contrast, the subsequent constant NO production
was found to be Ca2+ and G-protein independent (i.e., “dec-
entralized” mechanotransduction). A more recent study
found that the initial velocity acceleration-dependent signal
for NO release requires platelet/endothelial cell adhesion
molecule-1 (PECAM-1) [17]. PECAM-1, which acts as an
intracellular bridge between the two plasma membranes of
neighboring cells, is complexed with endothelial nitric oxide
synthase (eNOS) at the cell-cell junction. Velocity accelera-
tion is thought to deform the endothelial cell plasma mem-
brane and activate PCAM-1 [95]. The velocity acceleration-
dependent burst is consistent with previous in vitro observa-
tions [96, 97] for ﬂow-mediated release of PGI2 and for the
stimulation of NO release by Ca2+ mobilizing agonists [98].
Similar ﬁndings have been observed in isolated perfused
vessels exposed to acute changes in ﬂow [41, 94, 99].
Recently, we studied the eﬀect of velocity acceleration on
FMD in a group of 14 healthy, young, male subjects [100].
FMD was measured prior to, and following, increases in
velocity acceleration. Velocity acceleration was increased by
inﬂating a tourniquet to 40mmHg around the forearm. We
found a 14% increase in velocity acceleration-attenuated
FMD by 11%. This ﬁnding suggests that mean blood velocity
alone may not adequately characterize the shear stimulus.
Attention to secondary ﬂow phenomena may be particularly6 International Journal of Vascular Medicine
important when comparing groups with known secondary
ﬂow abnormalities.
6.3.PotentialLimitationsof InVitroStudies. Therelevanceof
ﬁndings garnered from in vitro studies bear two important
limitations. Firstly, endothelial cells from diﬀerent tissue
beds have been shown to exhibit diﬀerent responses for a
given ﬂow paradigm [101]. For instance, it has been shown
that diﬀerent tissue beds exhibit diﬀerent optimal ﬂow fre-
quencies for proliferation, eNOS activity, and PGI2 secretion
[101].Secondly,most culturestudies haveinvestigated endo-
thelialgeneregulationinresponsetoasingletypeofstimulus
(continuous laminar shear stress). Therefore, although these
simple in vitro models have yielded valuable information,
they fail to mimic the complexities of the in vivo environ-
ment. The applicability of these ﬁndings to humans remains
to be determined.
7. VelocityAcceleration andVascular Health
The eﬀects of velocity acceleration on the development of
atherosclerosis have produced conﬂicting ﬁndings. Bao et al.
[60] found that velocity acceleration upregulated the expres-
sion of putative atherogenic genes (monocyte chemoattrac-
tant protein-1 and platelet-derived growth factor-A) which
are believed to participate in the early events of atheroscle-
rosis [102, 103]. The same group found that velocity acce-
leration upregulates endothelial cell proliferation [62]. How-
ever, a more recent study by Hsiai et al. [81] found that pul-
satile ﬂow actually downregulated the expression of mono-
cyte chemoattractantprotein-1 and reduced monocyte bind-
ing to lipid-oxidized endothelial cells. Furthermore, they
found that the eﬀects were more exaggerated for pulsatile
ﬂowwithhighvelocityaccelerationversuspulsatileﬂowwith
low velocity acceleration, even though mean shear stress was
equivalent (50dyne/cm2).
Apart from the use of diﬀerent endothelial cell cultures
(bovine aortic [60] versus human umbilical [81]), a funda-
mental diﬀerence between the two aforementioned studies
lies in the ﬂow paradigms utilized. Bao et al. [60]e v o k e da
single ﬂow impulse (abrupt 0 to 16dyne/cm2 sustained for
3 seconds), whereas Hsiai et al. [81] evoked pulsatile ﬂow
with a mean shear stress of 50dyne/cm2. Notably, the Hsiai
et al. [81] ﬂow model did not permit shear stress to return
to zero between ﬂow impulses, thereby, inducing a steady
ﬂow component. However, when Hsiai et al. [81]p r o d u c e d
an oscillating ﬂow proﬁle (0 ± 5dyne/cm 2), which induced
high velocity acceleration but had a mean shear stress of
0dyne/cm 2 and was devoid of a steady ﬂow component,
monocyte chemoattractant protein-1 expression was upreg-
ulated and monocyte binding was increased. This is con-
sistent with the notion that, while endothelial cells derive
directional cues from the ﬂow direction or velocity, a certain
persistence of the stimulus is required [86, 89]. Taken toge-
ther,theseﬁndingssuggestthatendothelialcellsareregulated
by a complex interplay between steady ﬂow/shear stress and
velocity acceleration.
In vivo, ﬂow is pulsatile everywhere in the arterial system,
but in most places there is a large steady component. How-
ever, at sites where ﬂow oscillates with a low steady compo-
nent,atheroscleroticlesionsareknowntooccur.Again,thisis
consistent with the notion that while endothelial cells derive
directional cues from the ﬂow direction or velocity accelera-
tion, acertainpersistenceofthestimulus is required[86,89].
Steady shear stress results in the continuous upregulation of
antiatherogenic genes (manganese superoxide dismutase,
cyclooxygenase-2, eNOS) [104]. Steady shear also promotes
endothelial cell release of various bioactive substances that
may be involved in the regulation of atherogenic genes, such
as NO [105, 106]. These ﬁndings suggest that the production
of atherogenic genes by endothelial cells is regulated by the
complexinteractionbetweenvelocityaccelerationandsteady
ﬂow components.
7.1. Determinants of Velocity Acceleration. Velocity accelera-
tion is altered by diseased states. Decreased velocity accelera-
tionisseenwithventricularischemia[107],acutemyocardial
infarction [108], and stenoses [109]; increased velocity accel-
eration occurs with hypertension [110], hyperthyroidism
[111], bypass grafts [112], and obstruction of the lumen
[113]. Velocity acceleration is also decreased by aging [110]
and increased with physical activity [114–116]a n dv a s c u l a r
resistance [110, 117, 118]. Inadequate deﬁnition of the shear
stimulus may hinder comparisons between the aforemen-
tioned patient groups, who exhibit diﬀering rates of velocity
acceleration even though mean blood velocities may be com-
parable. Therapies that aﬀect velocity acceleration may also
complicate longitudinal observations on patient groups.
8.CalculatingShearStress
FuturestudiesusingtheFMDtestshouldconsider bothtime-
averaged mean blood velocity and secondary ﬂow parame-
ters, particularly when making between-group comparisons.
Emphasis is placed on the word consider since the FMD test
should not be normalized to shear stress using conventional
approaches. A number of studies have normalized the FMD
response through dividing FMD by the shear stimulus or
using an analysis of covariance (ANCOVA) approach [49,
119–123]. However, when using a General Linear Model
(GLM), the following assumptions must hold true: (1) there
must be at least a moderate correlation between the two
variables (i.e., shear and FMD); (2) the relationship between
shear and diameter must be linear; (3) the intercept for the
regression slope must be zero; (4) variance must be similar
between groups; (5) data must be normally distributed [121,
124]. A recent study found that that all assumptions for
reliable use of shear-diameter ratios were violated [122].
The FMD response (i.e., change in diameter) can be nor-
malized to the shear stimuli using hierarchical linear mod-
eling (HLM) [125]. The advantage of HLM is that it allows
the researcher to look at hierarchically structured data and
interpret results without ignoring these structures. This is
accomplished in HLM by including a complex random sub-
ject eﬀect which can appropriately account for correlations
among the data. This approach models diﬀerent patterns ofInternational Journal of Vascular Medicine 7
growth trajectories by allowing for the intercepts (initial dia-
meter) and slopes (shear rate diameter) to randomly vary. A
third level may also be speciﬁed: the speciﬁcation of groups
(e.g., to delineate diﬀerences in endothelial function) and/or
the speciﬁcation of an intervention or a modiﬁable risk fac-
tor such as smoking. This approach has previously been used
to compare upper versus lower extremity arterial health
in persons with spinal cord injury (SCI) [126], to assess
improvements in arterial health following electrical stimu-
lation-evoked resistance exercise therapy in persons with
SCI [127], and to assess the eﬀects of occasional cigarette
smoking on arterial health [28]. The disadvantage of this
approach is that multiple stimuli (preferably ranging from
minimal to maximal shear stimuli) are required to generate a
reliable shear-diameter slope; this results in lengthened test-
ing time and potentially makes it more diﬃcult to ascertain
the mechanism(s) resulting in dilation.
9. Conclusions
Pulsatile ﬂow, present throughout the arterial tree, results in
endothelial cells being exposed to two distinct shear stimuli
during the cardiac cycle: a large rate of change (velocity acce-
leration) in shear at the onset of ﬂow, followed by relati-
vely steady shear. In vitro studies suggest that these two dis-
tinct ﬂuid stimuli (velocity acceleration versus steady shear)
regulate short- and long-term endothelial function via in-
dependent biomechanical pathways. Studies have shown that
the rate of velocity acceleration can aﬀect mechanotransduc-
tion, vascular tone, and atherosclerosis. Velocity acceleration
may be altered in a number of diseased states, as well as by
aging and physical activity. Velocity acceleration may be an
important independent variable governing the shear stimu-
lus and should be considered when comparing groups with
known secondary ﬂow abnormalities.
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